NeutriSci Announces Initial 50,000 Unit NeuEnergy™ Program with Bulu Box
Vancouver, BC – NeutriSci International Inc. (TSX-V:NU) (the “Company” or “NeutriSci”) the innovator and pioneer behind NeuEnergy™, announces that it has entered into a long term retail and sampling program with Bulu Box to distribute 50,000 units of NeuEnergy™ to their health and wellness members.
Bulu Box is a discovery ecommerce company that features vitamin, supplement and healthy snack samples. The Bulu Box is the first health, nutrition and weight loss discovery box designed to help health conscious consumers feel their very best. Each month, a custom box arrives filled with a new mix of 4 to 5 premium samples. Each sample is large enough to allow consumers decide which product(s) are right for them and then they can follow up and purchase the items they like from Bulubox.com.
Some of the world’s largest brands such as Cliff Bar, Shapeology Nutrition, Quest Nutrition and Kind have partnered with Bulu Box to connect to customers and gain valuable customer data and insights and ultimately drive retail sales. More at BuluBox.com.
NeutriSci’s President Mr. Glen Rehman stated, “We are very proud to partner with Bulu Box and connect with consumers looking to discover new options for healthier living. During the next 60 days we will be preparing for the program to launch in October when Bulu Box will initially expose 50,000 of their targeted consumers to customized boxes of premium health products, which will include NeuEnergy™. Members will be incentivized to share their thoughts and spread the word about NeuEnergy’s ability to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. This latest addition to our current sales and distribution program further demonstrates industry and consumer demand for an alternative energy product.”
NeuEnergy™ is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more, or order NeuEnergy™ , visit www.getneuenergy.com.
About NeutriSci International Inc.:
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
Tel: (403) 264-6320
Investor Relations Contact:
KIN Communications Inc
Fred Leigh, VP Investor Relations
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.